{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:11:02Z","timestamp":1792188662213,"version":"4.4.0"},"reference-count":87,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Diabetic macular edema (DME) causes visual impairment in diabetic retinopathy (DR). Diabetes mellitus is a global epidemic and diabetic individuals are at risk of developing DR. Approximately 1 in 10 diabetic patients suffers from DME, which is the commonest cause of vision-threatening DR at primary-care screening. Furthermore, diabetes predisposes to a higher frequency and a younger onset of cataract, which further threatens vision in DME patients. Although cataract extraction is an effective cure, vision may still deteriorate following cataract surgery due to DME progression or recurrence, of which the risks are significantly higher than for patients without concurrent or previous history of DME at the time of operation. The management of pre-existing DME with visually significant cataract is a clinical conundrum. Deferring cataract surgery until DME is adequately treated is not ideal because of prolonged visual impairment and maturation of cataract jeopardizing surgical safety and monitoring of DR. On the other hand, the progression or recurrence of DME following prompt cataract surgery is a profound disappointment for patients and ophthalmic surgeons who had high expectations for postoperative visual improvement. Prescription of perioperative anti-inflammatory eye drops is effective in lowering the risk of new-onset DME after cataract surgery. However, management of concurrent DME at the time of cataract surgery is much more challenging because DME is unlikely to resolve spontaneously even with the aid of anti-inflammatory non-steroidal or steroid eye drops. A number of clinical trials using intravitreal injection of corticosteroids and anti-vascular endothelial growth factor (anti-VEGF) as first-line therapy have demonstrated safety and efficacy to treat DME. These drugs have also been administered perioperatively for the prevention of DME worsening in patients undergoing cataract surgery. This article reviews the scientific evidence to guide ophthalmologists on the efficacy and safety of various therapies for managing patients with DME who are particularly vulnerable to cataract surgery-induced inflammation, which disintegrates the blood\u2013retinal barrier and egression of fluid in macular edema.<\/jats:p>","DOI":"10.3389\/fendo.2023.1106706","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T06:06:16Z","timestamp":1674626776000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Optimizing treatment for diabetic macular edema during cataract surgery"],"prefix":"10.3389","volume":"14","author":[{"given":"Leo Ka Yu","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sui Sum","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny Siu-Chun","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"key":"B1","first-page":"1","article-title":"Diabetes epidemic, epidemiology, statistics and trends","volume-title":"Diabetes and the eye : Latest concepts and practices. diabetes, current and future developments volume 2","author":"Hendrick","year":"2021"},{"key":"B2","volume-title":"International diabetes federation. IDF diabetes atlas","year":"2009"},{"key":"B3","volume-title":"International diabetes federation. IDF diabetes atlas","year":"2011"},{"key":"B4","volume-title":"International diabetes federation. IDF diabetes atlas","year":"2013"},{"key":"B5","volume-title":"International diabetes federation. IDF diabetes atlas","year":"2015"},{"key":"B6","first-page":"147","volume-title":"International diabetes federation. IDF diabetes atlas","year":"2017"},{"key":"B7","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes - global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061816","article-title":"Diabetic retinopathy: Pathophysiology and treatments","volume":"19","author":"Wang","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40662-015-0026-2","article-title":"Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss","volume":"2","author":"Lee","year":"2015","journal-title":"Eye Vis (Lond)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: Systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/1120672119830578","article-title":"Prevalence of diabetes and diabetic macular edema in patients undergoing senile cataract surgery in Italy: The DIabetes and CATaract study","volume":"30","author":"Panozzo","year":"2020","journal-title":"Eur J Ophthalmol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-019-01466-8","article-title":"Diabetes and diabetic retinopathy in patients undergoing cataract surgery: A prevalence study-DiCat study report 2","volume":"57","author":"Rossi","year":"2020","journal-title":"Acta Diabetol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2156273","DOI":"10.1155\/2016\/2156273","article-title":"Diabetic macular edema pathophysiology: Vasogenic versus inflammatory","volume":"2016","author":"Romero-Aroca","year":"2016","journal-title":"J Diabetes Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12520","article-title":"The association between HbA1c and other biomarkers with the prevalence and severity of diabetic retinopathy","volume":"13","author":"Almutairi","year":"2021","journal-title":"Cureus"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-1472","article-title":"Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: A systematic review","volume":"48","author":"Virgili","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4103\/0974-9233.151887","article-title":"Imaging in diabetic retinopathy","volume":"22","author":"Salz","year":"2015","journal-title":"Middle East Afr J Ophthalmol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta17510","article-title":"Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: A prospective, multicentre, UK study","volume":"17","author":"Olson","year":"2013","journal-title":"Health Technol Assess"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2022.01.009","article-title":"Prevalence of diabetic macular edema based on optical coherence tomography in people with diabetes: A systematic review and meta-analysis","volume":"67","author":"Im","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0140-6736(05)70803-5","article-title":"Age-related cataract","volume":"365","author":"Asbell","year":"2005","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"608751","DOI":"10.1155\/2010\/608751","article-title":"Diabetic cataract-pathogenesis, epidemiology and treatment","volume":"2010","author":"Pollreisz","year":"2010","journal-title":"J Ophthalmol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v10.i3.140","article-title":"Cataract in diabetes mellitus","volume":"10","author":"Kiziltoprak","year":"2019","journal-title":"World J Diabetes"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(85)33877-0","article-title":"Prevalence of cataracts in a population-based study of persons with diabetes mellitus","volume":"92","author":"Klein","year":"1985","journal-title":"Ophthalmol"},{"key":"B24","first-page":"52","article-title":"Cataracts in diabetic patients: A review article","volume":"3","author":"Javadi","year":"2008","journal-title":"J Ophthalmic Vis Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1755-3768.1984.tb03972.x","article-title":"The prevalence of cataract in insulin-dependent and non-insulin-dependent-diabetes mellitus","volume":"62","author":"Nielsen","year":"1984","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0002-9394(14)71170-5","article-title":"Incidence of cataract surgery in the Wisconsin epidemiologic study of diabetic retinopathy","volume":"119","author":"Klein","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-017-0003-1","article-title":"Cataract in patients with diabetes mellitus-incidence rates in the UK and risk factors","volume":"32","author":"Becker","year":"2018","journal-title":"Eye (Lond)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s44197-021-00020-6","article-title":"Senile cataract in patients with diabetes with and without diabetic retinopathy: A community-based comparative study","volume":"12","author":"Alabdulwahhab","year":"2022","journal-title":"J Epidemiol Glob Health"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.03.024","article-title":"Diabetic macular edema: Pathophysiology and novel therapeutic targets","volume":"122","author":"Das","year":"2015","journal-title":"Ophthalmology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: A unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exer.2014.05.005","article-title":"Ion channels and transporters of the retinal pigment epithelium","volume":"126","author":"Reichhart","year":"2014","journal-title":"Exp Eye Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2016.08.001","article-title":"The importance of glial cells in the homeostasis of the retinal microenvironment and their pivotal role in the course of diabetic retinopathy","volume":"162","author":"Sorrentino","year":"2016","journal-title":"Life Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10456-007-9065-1","article-title":"Development of the retinal vasculature","volume":"10","author":"Fruttiger","year":"2007","journal-title":"Angiogenesis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.preteyeres.2013.02.001","article-title":"Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions","volume":"34","author":"Klaassen","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23082","article-title":"Comparative electrophysiology of retinal Muller glial cells-a survey on vertebrate species","volume":"65","author":"Pannicke","year":"2017","journal-title":"Glia"},{"key":"B36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.preteyeres.2017.10.006","article-title":"Mechanisms of macular edema: Beyond the surface","volume":"63","author":"Daruich","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1056\/NEJMra021678","article-title":"Diabetic retinopathy","volume":"350","author":"Frank","year":"2004","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12955-017-0751-4","article-title":"Vision-related quality of life and visual outcomes from cataract surgery in patients with vision-threatening diabetic retinopathy: A prospective observational study","volume":"15","author":"Zhu","year":"2017","journal-title":"Health Qual Life Outcomes"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.10.001","article-title":"Risk factors and incidence of macular edema after cataract surgery: A database study of 81984 eyes","volume":"123","author":"Chu","year":"2016","journal-title":"Ophthalmology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/08820538.2017.1353817","article-title":"Cataract surgery in patients with diabetes: Management strategies","volume":"33","author":"Peterson","year":"2018","journal-title":"Semin Ophthalmol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0202347","DOI":"10.1371\/journal.pone.0202347","article-title":"Development of diabetic retinopathy after cataract surgery","volume":"13","author":"Jeng","year":"2018","journal-title":"PloS One"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.03.003","article-title":"Development and progression of diabetic retinopathy 12 months after phacoemulsification cataract surgery","volume":"116","author":"Hong","year":"2009","journal-title":"Ophthalmology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2019.12.018","article-title":"Visual acuity outcomes after cataract extraction with intraocular lens implantation in eyes with diabetic retinopathy","volume":"4","author":"Han","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1158_17","article-title":"Cataract surgery in diabetes mellitus: A systematic review","volume":"66","author":"Kelkar","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S132810","article-title":"Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: Patient selection and perspectives","volume":"11","author":"Yuksel","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000328","article-title":"Management of macular oedema in diabetic patients undergoing cataract surgery","volume":"28","author":"Boscia","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S31902","article-title":"Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy","volume":"6","author":"Singh","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.01.036","article-title":"Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: Results of 2 randomized phase 3 studies","volume":"124","author":"Singh","year":"2017","journal-title":"Ophthalmol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2018.04.13","article-title":"Impact of topical nonsteroidal anti-inflammatory drugs in prevention of macular edema following cataract surgery in diabetic patients","volume":"11","author":"Alnagdy","year":"2018","journal-title":"Int J Ophthalmol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3341\/kjo.2019.0044","article-title":"Effect of 0.1% bromfenac for preventing macular edema after cataract surgery in patients with diabetes","volume":"34","author":"Song","year":"2020","journal-title":"Korean J Ophthalmol"},{"key":"B51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.17925\/EOR.2019.13.1.37","article-title":"Post-cataract cystoid macular oedema prevention \u2013 update 2019","volume":"13","author":"Mikalauskiene","year":"2019","journal-title":"Eur Ophthalmic Rev"},{"key":"B52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3325\/cmj.2017.58.49","article-title":"Effect of preoperative topical diclofenac on intraocular interleukin-12 concentration and macular edema after cataract surgery in patients with diabetic retinopathy: a randomized controlled trial","volume":"58","author":"Medic","year":"2017","journal-title":"Croat Med J"},{"key":"B53","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ajo.2015.07.032","article-title":"Prevention of cystoid macular edema after cataract surgery in nondiabetic and diabetic patients: A systematic review and meta-analysis","volume":"160","author":"Wielders","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2018.01.029","article-title":"European Multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1","volume":"44","author":"Wielders","year":"2018","journal-title":"J Cataract Refract Surg"},{"key":"B55","article-title":"Photocoagulation for diabetic macular edema: Early treatment diabetic retinopathy study report no. 4. the early treatment diabetic retinopathy study research group","volume":"27","year":"1987","journal-title":"Int Ophthalmol Clin"},{"key":"B56","article-title":"Early photocoagulation for diabetic retinopathy. ETDRS report number 9. early treatment diabetic retinopathy study research group","volume":"98","year":"1991","journal-title":"Ophthalmol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.2174\/1573399810666140402123026","article-title":"Laser treatment for diabetic macular edema in the 21st century","volume":"10","author":"Romero-Aroca","year":"2014","journal-title":"Curr Diabetes Rev"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.79.4.318","article-title":"Diode laser photocoagulation for diabetic macular oedema","volume":"79","author":"Ulbig","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200408000-00002","article-title":"Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy","volume":"24","author":"Maeshima","year":"2004","journal-title":"Retina"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701686","article-title":"Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: A 6-month prospective pilot study","volume":"19","author":"Lam","year":"2005","journal-title":"Eye (Lond)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2415-5-15","article-title":"The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract","volume":"5","author":"Habib","year":"2005","journal-title":"BMC Ophthalmol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.12720","article-title":"Diabetic macular edema at the time of cataract surgery trial: A prospective, randomized clinical trial of intravitreous bevacizumab versus triamcinolone in patients with diabetic macular oedema at the time of cataract surgery \u2013 preliminary 6 month results","volume":"44","author":"Lim","year":"2016","journal-title":"Clin Exp Ophthalmol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-313437","article-title":"Prospective randomised clinical trial of intravitreal bevacizumab versus triamcinolone in eyes with diabetic macular oedema undergoing cataract surgery: 6-month results","volume":"103","author":"Kandasamy","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"7945619","DOI":"10.1155\/2016\/7945619","article-title":"Comparison of perioperative ranibizumab injections for diabetic macular edema in patients undergoing cataract surgery","volume":"2016","author":"Yumusak","year":"2016","journal-title":"J Ophthalmol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030115","article-title":"Therapeutic effect of cataract surgery with simultaneous intravitreal injection of aflibercept on diabetic macular edema: An observational study","volume":"101","author":"Yen","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00018-6","article-title":"Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials","volume":"399","author":"Wykoff","year":"2022","journal-title":"Lancet"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000849","article-title":"Brolucizumab for the treatment of diabetic macular edema","volume":"33","author":"Kuo","year":"2022","journal-title":"Curr Opin Ophthalmol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ophtha.2010.02.031","article-title":"Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema","volume":"117","author":"Elman","year":"2010","journal-title":"Ophthalmol"},{"key":"B69","volume-title":"Advocating for improved treatment and outcomes for diabetic macular edema. a report based on an international expert summit convened in Paris","year":"2014"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2012.1107","article-title":"Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab","volume":"130","author":"Bressler","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000487548","article-title":"Short-term results of intravitreal triamcinolone acetonide combined with cataract surgery for diabetic macular edema in Japan: In the era of anti-vascular endothelial growth factor therapy","volume":"240","author":"Nunome","year":"2018","journal-title":"Ophthalmologica"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjopt.2015.10.004","article-title":"The combination of phacoemulsification surgery and intravitreal triamcinolone injection in patients with cataract and diabetic macular edema","volume":"30","author":"Ozgur","year":"2016","journal-title":"Saudi J Ophthalmol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3341\/kjo.2016.30.1.25","article-title":"Effect of posterior subtenon triamcinolone acetonide injection on diabetic macular edema refractory to intravitreal bevacizumab injection","volume":"30","author":"Kim","year":"2016","journal-title":"Korean J Ophthalmol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s12886-022-02625-2","article-title":"Comparison between intravitreal ranibizumab injection and posterior subtenon triamcinolone acetonide injection at time of cataract surgery for prevention of progression of diabetic macular edema","volume":"22","author":"Khalil","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.04.030","article-title":"Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema","volume":"119","author":"Campochiaro","year":"2012","journal-title":"Ophthalmol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.ophtha.2010.12.028","article-title":"Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema","volume":"118","author":"Campochiaro","year":"2011","journal-title":"Ophthalmol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2017.1363182","article-title":"Fluocinolone acetonide for the treatment of diabetic macular edema","volume":"18","author":"Veritti","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2015.98","article-title":"Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants","volume":"29","author":"Yang","year":"2015","journal-title":"Eye (Lond)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-5285","article-title":"Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant","volume":"52","author":"Chang-Lin","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B80","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/IAE.0b013e318188c814","article-title":"Evaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edema","volume":"29","author":"Haller","year":"2009","journal-title":"Retina"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.125.3.309","article-title":"Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema","volume":"125","author":"Kuppermann","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-011-0019-z","article-title":"The dexamethasone drug delivery system: indications and evidence","volume":"28","author":"London","year":"2011","journal-title":"Adv Ther"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001552","article-title":"Effect of an intravitreal dexamethasone implant on diabetic macular edema after cataract surgery","volume":"38","author":"Calvo","year":"2018","journal-title":"Retina"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.08.002","article-title":"Dexamethasone intravitreal implant during phacoemulsification","volume":"120","author":"Agarwal","year":"2013","journal-title":"Ophthalmol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318206d18c","article-title":"Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients","volume":"31","author":"Boyer","year":"2011","journal-title":"Retina"},{"key":"B86","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12886-019-1122-1","article-title":"Risk factors for and management of anterior chamber intravitreal dexamethasone implant migration","volume":"19","author":"Rock","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/ICU.0b013e32834cd5f8","article-title":"Pseudophakic cystoid macular edema","volume":"23","author":"Yonekawa","year":"2012","journal-title":"Curr Opin Ophthalmol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1106706\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T06:06:28Z","timestamp":1674626788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1106706\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":87,"alternative-id":["10.3389\/fendo.2023.1106706"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1106706","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"article-number":"1106706"}}